Fast Biologic Peptide Mapping Analysis for Complete Coverage
Whether you are involved in biopharma discovery, early development or late development, you need fast and dependable peptide mapping analysis techniques that you can count on.
In early development candidate selection, determining the appropriate critical quality attributes (CQA) is paramount and depends on extremely complex data processing and analysis. In late development, throughput is your top priority so you can process and analyze high sample volumes, quickly. Although the requirements of peptide mapping analyses change during the development pipeline, the need to store, access and share large data sets is consistent throughout.
With SCIEX mass spec solutions, you can now benefit from 100% sequence coverage in a single injection and see low level post-translational modifications – faster than ever before.
SCIEX combines cutting edge mass spectrometry technology into an integrated solution designed specifically to address the challenges of peptide mapping at all stages of the therapeutic development pipeline.
Comprehensive Sequence Analysis with CESI-MS
Experience the orthogonal separation technique of CESI-MS, providing 100% sequence coverage with a single injection, from a single protease digestion.
Peptide Analysis Becomes Routine with the X500B QTOF
Simplify and accelerate peptide mapping workflows with the powerful and intuitive X500B QTOF system that eliminates complex method development by using a generic data-independent SWATH® Acquisition method for the analysis of all detectable peptides in a sample.
Answers at the Speed of Light
Eliminate time consuming manual data analysis, interpretation and reporting with revolutionary BioPharmaView™ Software. Process large batches, annotate the peptide sequence and report detailed quantitation information – it’s automated and accurate.